Search results
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing...
StreetInsider· 4 days agoThe launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at...
Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
Digital Journal· 3 days agoSecond study arm dosing is now complete. KELOWNA, BC / ACCESSWIRE / June 5, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug ...
Aeterna Zentaris and Ceapro Complete Merger Transaction
Digital Journal· 5 days agoAeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two innovative biopharmaceutical development ...